Brief: Vigil Neuroscience Reports Third Quarter 2022 Results

Vigil Neuroscience

10/11/2022 12:32

Nov 10 (Reuters) - Vigil Neuroscience Inc  VIGL.O :
    * VIGIL NEUROSCIENCE REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * ANNOUNCED INTERIM TOPLINE DATA FROM PHASE 1 TRIAL OF
VGL101 IN
HEALTHY VOLUNTEERS
    * CASH AND CASH EQUIVALENTS WERE $203.9 MILLION AS OF
SEPTEMBER
30, 2022
    * QTRLY LOSS PER SHARE $0.53
    * Q3 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA
    * COMPLETED $75 MILLION PIPE FROM NEW AND EXISTING
INVESTORS,
EXTENDING CASH RUNWAY INTO Q1 OF 2025

Source text for Eikon:  ID:nGNX9Qjxh0 
Further company coverage:  VIGL.O 
 ((Reuters.Briefs@thomsonreuters.com;))